Improved Fetal Hemoglobin With mTOR Inhibitor-Based Immunosuppression in a Kidney Transplant Recipient With Sickle Cell Disease

American Journal of Transplantation - United Kingdom
doi 10.1111/ajt.14263
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Additive Effect of Sirolimus and Hydroxycarbamide on Fetal Haemoglobin Level in Kidney Transplant Patients With Sickle Cell Disease

British Journal of Haematology
Hematology
2018English

Hereditary Persistence of Fetal Hemoglobin-Sickle Cell Disease Syndrome

2020English

Long‑term Survival in a Recipient of Kidney Transplant Without Maintenance Immunosuppression: A Case Report

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2018English

Fever in a Kidney Transplant Recipient

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2017English

Hydroxyurea Enhances Fetal Hemoglobin Production in Sickle Cell Anemia.

Journal of Clinical Investigation
Medicine
1984English

Pericardial Effusion With Necrotic Ventricular Mass in a Kidney Transplant Recipient

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2019English

Peripheral Blood Stem Cell Transplant-relatedPlasmodium Falciparuminfection in a Patient With Sickle Cell Disease

Transfusion
AllergyImmunologyHematology
2012English

Sickle Cell-Hemoglobin C Disease Syndrome

2020English

Invasive Pulmonary Aspergillosis in a Sickle Cell Patient Transplant Recipient: A Successful Treatment

Mediterranean Journal of Hematology and Infectious Diseases
Infectious DiseasesHematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy